Showing 76–100 of 200 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Mamadou Sow, Alioune Camara, Sidikiba Sidibé, Ibrahima Kaba, Nestor Niouma Leno, et al.
Introduction: The aim was to assess weight gain during tuberculosis treatment in patients co-infected with tuberculosis and HIV. Methods: Tuberculosis patients co-infected with HIV and undergoing tuberculosis treatment in the pneumophtisiology and infectious and tropical diseases…
Olivia Kamoen, Kenan Bosco, Liberius Libent, Colman E. Assenga, Eli Mkwizu, et al.
In sub-Saharan Africa (SSA) central nervous system (CNS) infections in patients with HIV/AIDS are a major cause of HIV-related mortality and morbidity. We describe a patient with a paraparesis after start of tuberculosis (TB) treatment. The patient had stage IV HIV and was not on…
Saavedra Cervera B, López MG, Chiner-Oms Á, García AM, Cancino-Muñoz I, et al.
Genomic studies of the Mycobacterium tuberculosis complex (MTBC) might shed light on the dynamics of its transmission, especially in high-burden settings, where recent outbreaks are embedded in the complex natural history of the disease. To this end, we conducted a 1 year prospec…
LaCourse SM, Seko E, Wood R, Bundi W, Ouma GS, et al.
Objective We evaluated diagnostic performance of oral swab analysis (OSA) for tuberculosis (TB) in a high HIV/TB burden setting in Kenya. Methods In this cross-sectional study, buccal swabs and sputum were collected from 100 participants with suspected TB in outpatient clinics in…
World Health Organization
Muhie NS
Background: Tuberculosis increases human immunodeficiency virus replication and accelerates human immunodeficiency virus progression in both tuberculosis and human immunodeficiency virus coinfected patients. The objective of this study was to determine the incidence rate, surviva…
World Health Organization
Jessica F Magidson, PhD, Bronwyn J Myers, PhD
Poor engagement in care contributes to HIV- and TB-related morbidity and mortality in South Africa (SA). Community health workers (CHWs) are frontline lay health workers who work to re-engage patients who are lost to follow-up (LTFU) in HIV/TB care. Patients with depression and s…
Mukisa Benjamin
Tuberculosis (TB) is a highly infectious disease caused by Mycobacterium tuberculosis, predominantly affecting the lungs and leading to a range of debilitating symptoms. It is a global health concern, with a significant impact on mortality. This study aimed to assess the prevalen…
Kaila Aguiar Soares, Joanna Ehrlich, M. L. de la Cámara, Souleymane Chaloub, Elom Emeka, et al.
<h3>Tweetable abstract</h3> <b>This study provides an update on the implementation of lateral flow LAM testing in national guidelines and identifies the major barriers that may be preventing widespread use of the test</b>https://bit.ly/44NfxZ3
World Health Organization
Modongo C, Wang Q, Dima M, Matsiri O, Kgwaadira B, et al.
Background Dolutegravir (DTG) has recently been recommended as a preferred first-line regimen for the treatment of new and treatment-experienced HIV-infected patients. However, potential drug interactions between DTG and rifampicin remain a clinical and public health concern. Met…
Jinhong He, Xiangxi He, Xiaoxin Xie, Yanhua Fu, Xingxing Luo, et al.
Introduction Co-infection with tuberculosis (TB) is the leading cause of death in individuals infected with human immunodeficiency virus (HIV)-1. Dolutegravir and lamivudine (DTG+3TC) has recently been recommended as the preferred first-line regimen for the treatment of new and t…
World Health Organization
Nyagosya Range, MSc, PhD, Henrik Friis, MD, PhD
We propose a randomised trial among pulmonary TB patients, examined and treated as part of the national TB control programme (WHO, 2003). The aim is to improve TB treatment outcome in high TB and HIV burden countries. The overall objective of the proposed trial is to assess the e…
World Health Organization. Regional Office for South-East Asia
Pean P, Madec Y, Nerrienet E, Borand L, Laureillard D, et al.
IRIS is a common complication in HIV-infected patients treated for tuberculosis (TB) and cART. Our aim was to evaluate NK cell reconstitution in HIV-infected patients with TB-IRIS compared to those without IRIS. 147 HIV-infected patients with TB from the CAMELIA trial were enroll…
Natalya V. Kuzmina, Н. В. Нелидова
The article describes a clinical case of Kaposi sarcoma in a patient with concurrent tuberculosis, HIV infection with severely compromised T-cell immunity, viral hepatitis B and C, and substances and alcohol abuse. Also, the patient had low adherence to treatment with anti-tuberc…
World Health Organization
Organisation mondiale de la Santé
Eang, Mao Tan, Chheng, Phalkun, Natpratan, Chawalit, Kimerling, Michael E
World Health Organization
Galyna kutsyna, MD, PhD
Dzherelo (Immunoxel) is an oral immunomodulating botanical agent available over-the-counter in Ukraine. After many years of laboratory and clinical testing the formulation was approved in 1997 by the Ministry of Health of Ukraine as a dietary herbal supplement, which enhances imm…
World Health Organization
World Health Organization